Korea University's Anam, Guro, Ansan Hospital, and Research-oriented Hospital Certification...Reaffirming R&D Leadership's Reputation
Mar 26, 2025
Anam, Guro, and Ansan hospitals under Korea University Medical Center (Ministry of Medicine and Medical Center Director Yoon Eul-sik) have reaffirmed their reputation as leading R&D medical institutions in Korea by obtaining certification as research-oriented hospitals.
In the Ministry of Health and Welfare's research-oriented hospital certification evaluation announced on the 26th, Korea University's Anam, Guro, and Ansan hospitals all passed the certification and were selected as the first research-oriented hospital in 2025 and will be certified for three years until 2028. Following Anam and Guro hospitals, which have maintained the title of research-oriented hospitals since 2013, Korea University Medical Center has been honored as the only medical institution in Korea with three research-oriented hospitals.
Korea University Anam Hospital has developed a cloud-based precision medical hospital information system and led the profiling of cancer genomes for the first time in Asia. It has established a 'medical R&D platform' in line with strategies in four key research areas: 'advanced medical biotechnology research group', 'innovative precision medicine', 'smart healthcare', and 'medical data science'. In addition, research-related governance capabilities are being maximized so that the cycle leading to research performance-research infrastructure-research support can be operated most closely and efficiently.
Korea University Guro Hospital has been constantly striving to expand the creation of research results through the establishment of sustainable research infrastructure, including key research platforms, and the advancement of R&D research support.
In addition, it has established an open convergence research infrastructure with industry, academia, and research by operating an open laboratory and G Valley Medical Device Development Support Center project, and is creating active domestic and international networking and global research capabilities and commercialization results by conducting R&D and global apple scholar training projects. In the past three years, 338 intellectual property rights (93 overseas applications, 11 tripolar patents) and 1216 SCI (E) research papers have been recorded, and 38 technology transfers and two subsidiaries have been established to produce tangible results in research-based medical industrialization.
Korea University Ansan Hospital has newly expanded its research space to strengthen its research capabilities, and has greatly expanded its animal and cell testing facilities. It is currently operating more than 30 advanced joint research equipment (Core Lab), and has also obtained approval from corporate-affiliated research institutes to promote commercialization of research results.
In addition, an average of 2.3 patents have been applied per key researcher over the past three years, and three new medical technologies have been approved over 2023 and 2024. A total of 131 clinical trials were approved and conducted, and more than 57 industry-academic joint studies were conducted. Through the operation of the SPARK program and technology transfer through the global network, a total of 29 technology transfers have been completed since November 2021.
Now that all affiliated hospitals have been certified as research-oriented hospitals, Korea University Medical Center plans to present a new model to the Korean medical community by establishing a full-fledged R&D-centered system and developing customized ultra-precise innovative medical technology to conquer severe incurable diseases to realize true life-respecting future medicine.
Vice-President of Medical Affairs Yoon Eul-sik said, `We are pleased that all hospitals belonging to the Korea University Medical Center are certified as research-oriented hospitals by the Ministry of Health and Welfare to promote research and development and technical commercialization. As the bio-health sector is a key national growth engine, we will do our best to create a virtuous cycle of ripple effects that contribute to the development of related industries through research advancement and technological commercialization of medical institutions."
In the Ministry of Health and Welfare's research-oriented hospital certification evaluation announced on the 26th, Korea University's Anam, Guro, and Ansan hospitals all passed the certification and were selected as the first research-oriented hospital in 2025 and will be certified for three years until 2028. Following Anam and Guro hospitals, which have maintained the title of research-oriented hospitals since 2013, Korea University Medical Center has been honored as the only medical institution in Korea with three research-oriented hospitals.
Korea University Anam Hospital has developed a cloud-based precision medical hospital information system and led the profiling of cancer genomes for the first time in Asia. It has established a 'medical R&D platform' in line with strategies in four key research areas: 'advanced medical biotechnology research group', 'innovative precision medicine', 'smart healthcare', and 'medical data science'. In addition, research-related governance capabilities are being maximized so that the cycle leading to research performance-research infrastructure-research support can be operated most closely and efficiently.
Korea University Guro Hospital has been constantly striving to expand the creation of research results through the establishment of sustainable research infrastructure, including key research platforms, and the advancement of R&D research support.
In addition, it has established an open convergence research infrastructure with industry, academia, and research by operating an open laboratory and G Valley Medical Device Development Support Center project, and is creating active domestic and international networking and global research capabilities and commercialization results by conducting R&D and global apple scholar training projects. In the past three years, 338 intellectual property rights (93 overseas applications, 11 tripolar patents) and 1216 SCI (E) research papers have been recorded, and 38 technology transfers and two subsidiaries have been established to produce tangible results in research-based medical industrialization.
Korea University Ansan Hospital has newly expanded its research space to strengthen its research capabilities, and has greatly expanded its animal and cell testing facilities. It is currently operating more than 30 advanced joint research equipment (Core Lab), and has also obtained approval from corporate-affiliated research institutes to promote commercialization of research results.
In addition, an average of 2.3 patents have been applied per key researcher over the past three years, and three new medical technologies have been approved over 2023 and 2024. A total of 131 clinical trials were approved and conducted, and more than 57 industry-academic joint studies were conducted. Through the operation of the SPARK program and technology transfer through the global network, a total of 29 technology transfers have been completed since November 2021.
Now that all affiliated hospitals have been certified as research-oriented hospitals, Korea University Medical Center plans to present a new model to the Korean medical community by establishing a full-fledged R&D-centered system and developing customized ultra-precise innovative medical technology to conquer severe incurable diseases to realize true life-respecting future medicine.
Vice-President of Medical Affairs Yoon Eul-sik said, `We are pleased that all hospitals belonging to the Korea University Medical Center are certified as research-oriented hospitals by the Ministry of Health and Welfare to promote research and development and technical commercialization. As the bio-health sector is a key national growth engine, we will do our best to create a virtuous cycle of ripple effects that contribute to the development of related industries through research advancement and technological commercialization of medical institutions."
|
This article was translated by Naver AI translator.
